Lipicure 5 Tablet contains Atorvastatin 5mg, a potent lipid-lowering agent belonging to the statin class of medications. It is primarily indicated for the treatment of hypercholesterolemia and mixed dyslipidemia to reduce elevated total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides, while increasing high-density lipoprotein cholesterol (HDL-C). Atorvastatin exerts its effect by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, leading to decreased cholesterol production in the liver and increased clearance of LDL from the bloodstream. Lipicure 5 is used as an adjunct to diet and lifestyle modifications, including exercise and weight control, to achieve optimal lipid levels and reduce the risk of cardiovascular events such as myocardial infarction, stroke, and angina in patients with atherosclerotic cardiovascular disease or those at high risk. The recommended dosage is individualized based on patient response and lipid profile, with regular monitoring of liver function tests and lipid levels advised during therapy. Caution is warranted in patients with hepatic impairment, and potential drug interactions should be assessed prior to initiation. Lipicure 5 is contraindicated in pregnancy and lactation due to potential teratogenic effects.